India faces a growing diabetes crisis with over 101 million affected. Significant gaps in diagnosis, patient education, and complication screening require urgent attention through better ... Aug 21
Fatty liver and diabetes share insulin resistance as a common root cause, creating a harmful cycle that millions of Indian patients face silently. Early awareness, ... Jun 18
Across the landscape of global biotech companies, the appointment of a senior executive often serves as a "barometer"—offering insights into a company's pipeline ... Apr 04
In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint. In ACHIEVE-5, orforglipron ... Oct 16
In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint. In ACHIEVE-5, orforglipron ... Oct 15
A study published in a major medical journal revealed that individuals with type 2 diabetes who were treated with SGLT-2 inhibitors had a lower ... Aug 30
Glenmark's commitment to providing affordable and effective solutions highlights its role as a leader in diabetes care. As Zita DM becomes a part of ... Oct 19
-Advertisements-
.jpeg)
Thursday, October 08, 2026
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)